A database of FDA approved therapeutic peptides and proteins
ID1055 | ThPPIDTh1009 | NameAlteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandActivase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous | CategoryThrombolytic Agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1067 | ThPPIDTh1012 | NameReteplase | Peptide SequenceSYQGNSDCYFGNGSAYRGTH Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandRetavase | CompanyCentocor | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryFibrinolytic Agents, Thrombolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1201 | ThPPIDTh1026 | NameAnistreplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIc | DiseaseHematological,Metabolic | BrandEminase | CompanyWulfing Pharma GmbH | Physical AppearanceDry powder | Route of AdministartionIntravenous infusion | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1210 | ThPPIDTh1028 | NameTenecteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandTNKase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1,Plasminogen activator inhibitor 2,Tetranectin,Keratin, type II cytoskeletal 8,Annexin A2,Calreticulin,Calnexin,Prolow-density lipoprotein |
ID1234 | ThPPIDTh1032 | NameCoagulation factor VIIa | Peptide SequenceANAFLEELRPGSLERECKEE Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandNovoSeven | CompanyNovo Nordisk | Physical AppearanceSterile, white lyophilized powder | Route of AdministartionInjection | CategoryThrombotic Agents, Coagulants | TargetCoagulation factor X,Serine protease hepsin,Tissue factor pathway inhibitor,Vitamin K-dependent gamma-carboxylase,Coagulation factor VII,Tissue factor |
ID1659 | ThPPIDTh1152 | NameDrotrecogin alfa | Peptide SequenceHeavy Chain: LIDGKMT Full view | Length402 | Functional ClassificationIb | DiseaseInfectious | BrandXigris | CompanyEli Lilly and Company | Physical AppearanceSterile, lyophilized, white to off-white powder | Route of AdministartionIntravenous Infusion | CategoryAntisepsis | TargetCoagulation factor VIII, V, Plasminogen activator inhibitor 1, Thrombomodulin, Vitamin K-dependent protein S, Ceruloplasmin, Prothrombin, Platelet factor 4, Plasma serine protease inhibitor, Serpin B6, Vitamin K-dependent gamma-carboxylase, Endothelial protein C receptor |
ID1663 | ThPPIDTh1155 | NameUrokinase | Peptide SequenceKPSSPPEELKFQCGQKTLRP Full view | Length276 | Functional ClassificationIb | DiseaseHaemetological | BrandKinlytic | CompanyN.A. | Physical AppearanceSterile lyophilized white powder | Route of AdministartionIntravenous infusion | CategoryN.A. | TargetPlasminogen,Urokinase plasminogen activator surface receptor, Urokinase-type plasminogen activator, Tissue-type plasminogen activator, Plasminogen activator inhibitor 1, 2, Plasma serine protease inhibitor, Low-density lipoprotein receptor-related protein 2, Suppressor of tumorigenicity 14 protein, Nidogen-1 |
ID1715 | ThPPIDTh1171 | NameC1 Esterase Inhibitor (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandBerinert 1500 | CompanyCsl Behring Canada Inc | Physical Appearancekit; Powder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetPlasma protease C1 inhibitor |
ID1717 | ThPPIDTh1171 | NameC1 Esterase Inhibitor (Human) | Peptide SequenceNA Full view | Length0 | Functional ClassificationIa | DiseaseGenetic Disorders | BrandCinryze | CompanyViropharma Biologics Inc | Physical AppearancePowder for Solution | Route of AdministartionIntravenous | CategoryNA | TargetPlasma protease C1 inhibitor |